Table 1.
Descriptive characteristics of the participants.
| Outcome | All (n = 23) | Cerebral Palsy (n = 11) |
|---|---|---|
| Age (yr), mean (SD) | 10 ± 3 (5–18) | 11 ± 4 (5–18) |
| Gender, n females (%) | 10 (44%) | 4 (36%) |
| Height (cm), mean (SD) | 129.2 ± 19.9 | 135.5 ± 17.9 |
| Weight (kg), mean (SD) | 33.2 ± 12.5 | 34.6 ± 12.3 |
| GMFCS, n (%) | ||
| Level I | 13 (57%) | 5 (46%) |
| Level II | 4 (17%) | 1 (9%) |
| Level II | 6 (26%) | 5 (46%) |
| Coginitive, n (%) | ||
| Average | 12 (57%) | 7 (33%) |
| Mild impairment | 7 (33%) | 2 (18%) |
| Moderate impairment | 4 (19%) | 2 (18%) |
| School type, n (%) | ||
| Main stream (included) | 19 (90%) | 9 (82%) |
| Main stream (self-contained) | 2 (10%) | 1 (9%) |
| Special school | 2 (10%) | 1 (9%) |
| Clinical diagnosis, n (%) | ||
| Cerebral palsy | 11 (48%) | 11 (100%) |
| Prader–Willi syndrome | 3 (13%) | - |
| Williams syndrome | 1 (4%) | - |
| Spina bifida | 1 (4%) | - |
| Diencephalic brain tumor | 1 (4%) | - |
| Autism spectrum disorder | 1 (4%) | - |
| Achondroplasia | 1 (4%) | - |
| Metabolic disease | 2 (9%) | - |
| Congenital malformation of upper limbs | 1 (4%) | - |